Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real-World Experience From the Nationwide Taiwan Hepatitis C Virus Registry.
Hu PJ, Tsai PC, Chen CY, Kuo HT, Hung CH, Tseng KC, Lai HC, Peng CY, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, Lo GH, Kao JH, Liu CJ, Liu CH, Yan SL, Lin CY, Su WW, Chu CH, Chen CJ, Tung SY, Tai CM, Lin CW, Lo CC, Cheng PN, Chiu YC, Wang CC, Cheng JS, Tsai WL, Lin HC, Huang YH, Yeh ML, Huang CF, Hsieh MH, Huang JF, Dai CY, Chung WL, Wang YH, Yu ML, Bair MJ; T‐COACH Study Group.
Hu PJ, et al. Among authors: cheng js.
Kaohsiung J Med Sci. 2025 Aug;41(8):e70036. doi: 10.1002/kjm2.70036. Epub 2025 May 24.
Kaohsiung J Med Sci. 2025.
PMID: 40411291
Free PMC article.